Lippman Evan
EVP, Business Development · 4 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 35,912 | $35.58 | $1.3M | filing |
| 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Sale | 5,746 | $35.58 | $204,466.81 | filing |
| 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 11,841 | — | — | filing |
| 2026-05-14 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Option exercise | 74,008 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.